Literature DB >> 11040201

Tumor necrosis factor: biology and therapeutic inhibitors.

K A Papadakis1, S R Targan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11040201     DOI： 10.1053/gast.2000.18160

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  81 in total

1.  Life and death in the gut: more killing, less Crohn's.

Authors:  A Sturm; C Fiocchi
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

Review 3.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 4.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

5.  Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

6.  Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.

Authors:  Olga Chemnitzer; Katharina Götzel; Luisa Maurer; Arne Dietrich; Uwe Eichfeld; Orestis Lyros; Boris Jansen-Winkeln; Albrecht Hoffmeister; Ines Gockel; René Thieme
Journal:  Dig Dis Sci       Date:  2017-10-30       Impact factor: 3.199

7.  Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Authors:  T Luna; S B Santos; M Nascimento; M A F Porto; A L Muniz; E M Carvalho; A R Jesus
Journal:  Braz J Med Biol Res       Date:  2011-10-22       Impact factor: 2.590

8.  Probiotics promote gut health through stimulation of epithelial innate immunity.

Authors:  Cristiano Pagnini; Rubina Saeed; Giorgos Bamias; Kristen O Arseneau; Theresa T Pizarro; Fabio Cominelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.

Authors:  A Di Sabatino; R Ciccocioppo; B Cinque; D Millimaggi; R Morera; L Ricevuti; M G Cifone; G R Corazza
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

10.  Effectiveness of infliximab after adalimumab failure in Crohn's disease.

Authors:  María Chaparro; Montserrat Andreu; Manuel Barreiro-de Acosta; Esther García-Planella; Elena Ricart; Eugeni Domènech; María Esteve; Olga Merino; Pilar Nos; Mireia Peñalva; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2012-10-07       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.